Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone in Patients With Stage III-IV Head and Neck Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Emory University
Eastern Cooperative Oncology Group
Emory University
NRG Oncology
Tanabe Pharma America, Inc.
Mayo Clinic
Cedars-Sinai Medical Center
M.D. Anderson Cancer Center
Massive Bio, Inc.
Travera Inc
Turning Point Therapeutics, Inc.
Marengo Therapeutics, Inc.
Emory University
University of California, San Francisco
Simcha IL-18, Inc.
UNICANCER
Cancer Research UK
Evopoint Biosciences Inc.
Charite University, Berlin, Germany